Back
Sarepta Therapeutics, Inc. Vs. Avis Budget Group, Inc. Industry Stock Comparison
Sell
42
SRPT
Sarepta Therapeutics, Inc.
Last Price:
$21.23
Seasonality Move:
10.38%
Sell
36
CAR
Avis Budget Group, Inc.
Last Price:
$132.36
Seasonality Move:
3.84%
Sell
42
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Sarepta Therapeutics, Inc. [SRPT] share price is $21.04. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Avis Budget Group, Inc. (CAR)
is a Sell
Is Avis Budget Group, Inc. a Buy, Sell or Hold?
-
The current Avis Budget Group, Inc. [CAR] share price is $130.59. The Score for CAR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
CAR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRPT Stock Price Chart
What is Sarepta Therapeutics, Inc.'s stock price today?
-
The Sarepta Therapeutics, Inc. share price today is $21.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight buying pressure.
CAR Stock Price Chart
What is Avis Budget Group, Inc.'s stock price today?
-
The Avis Budget Group, Inc. share price today is $130.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CAR is experiencing slight buying pressure.
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.92 | Buy |
| Relative Strength Index (14 RSI): | 51.11 | Buy |
| Chaikin Money Flow: | 1527880 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.4 - 22.24) | Buy |
| Bollinger Bands (100): | (17.55 - 22.19) | Buy |
CAR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.29 | Sell |
| Relative Strength Index (14 RSI): | 44.65 | Sell |
| Chaikin Money Flow: | 181137 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (129.53 - 134.95) | Sell |
| Bollinger Bands (100): | (136.62 - 159.08) | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.48 | Sell |
| 20-day SMA: | 21.06 | Sell |
| 50-day SMA: | 20.78 | Buy |
| 200-day SMA: | 32.06 | Sell |
| 8-day EMA: | 11.03 | Buy |
| 20-day EMA: | 5.4 | Buy |
| 50-day EMA: | 2.36 | Buy |
| 200-day EMA: | 0.62 | Buy |
CAR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 131.4 | Sell |
| 20-day SMA: | 132.5 | Sell |
| 50-day SMA: | 138.94 | Sell |
| 200-day SMA: | 132.84 | Sell |
| 8-day EMA: | 130.98 | Sell |
| 20-day EMA: | 132.79 | Sell |
| 50-day EMA: | 138.3 | Sell |
| 200-day EMA: | 135.38 | Sell |
Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.60 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.03 per share, and an increase next year of $4.91 per share.
Avis Budget Group, Inc. Earnings Growth & CAR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.57 per share, and an increase next year of $0.82 per share.
Sarepta Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avis Budget Group, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||